| Zdroj: |
Tucker, L, Allen, A, Chandler, D, Ciurtin, C, Dick, A, Foulkes, A, Gullick, N, Helliwell, P, Jadon, D, Jones, G, Kyle, S, Madhok, V, McHugh, N, Parkinson, A, Raine, T, Siebert, S, Smith, C, Tillett, W & Coates, L C 2022, ' Executive summary : The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs ', Rheumatology (Oxford, England), vol. 61, no. 9, keac260, pp. 3514–3520 . https://doi.org/10.1093/rheumatology/keac260 |
